Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected IndividualsEdouard Januel, Ophelia Godin, Antoine Moulignier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2017
Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected IndividualsAntoine Moulignier, Julien Savatovsky, Lambert Assoumou, et al.
BMC Infectious Diseases|June 13, 2022
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort studyGuillaume Martin-Blondel, François-Xavier Lescure, Lambert Assoumou, et al.
Cell Reports. Medicine|August 25, 2020
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway EpitheliaAndrés Pizzorno, Blandine Padey, Thomas Julien, et al.
Wellcome Open Research|November 30, 2023
MOSAIC: A cohort study of human mpox virus diseaseElise Pesonel, Isabelle Hoffmann, Laetitia Guiraud, et al.
Critical Care (London, England)|November 18, 2016
Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumoniaGuillaume Voiriot, Benoit Visseaux, Johana Cohen, et al.
The Journal of Infection|July 4, 2020
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?Marie Gousseff, Pauline Penot, Laure Gallay, et al.
International Journal of Medical Microbiology : IJMM|February 12, 2025
Comparison of clinical metagenomics with 16S rDNA Sanger sequencing for the bacteriological diagnosis of culture-negative samplesCamille d'Humières, Skerdi Haviari, Marie Petitjean, et al.
The Lancet. Infectious Diseases|November 29, 2021
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trialConstance Delaugerre, Frantz Foissac, Hendy Abdoul, et al.
Lancet (London, England)|October 20, 2025
Cloxacillin versus cefazolin for meticillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): a prospective, open-label, multicentre, non-inferiority, randomised clinical trialCharles Burdet, Nadia Saïdani, Céline Dupieux, et al.
Pageof 15